What is an IGF-1 Blood Test?

The liver's stable proxy for growth hormone activity

Insulin-like growth factor 1 (IGF-1) is a protein hormone that circulates in the bloodstream and carries out growth signals. Most IGF-1 is made by the liver after stimulation from growth hormone released by the pituitary gland. Many tissues also make small amounts locally. In blood, IGF-1 travels mostly bound to carrier proteins (IGF-binding proteins, especially IGFBP-3), which extend its life and control its delivery to tissues. An IGF-1 blood test measures the amount of this hormone in circulation.

IGF-1 is the main messenger that translates growth hormone's prompts into actual tissue growth and repair. In childhood it drives height gain by supporting bone and cartilage development; throughout life it helps maintain muscle, bone strength, and organ function by promoting cell growth and protein building (anabolism). Because IGF-1 changes slowly across the day and reflects the body's average growth hormone activity, its level serves as a steady indicator of the GH–IGF axis. IGF-1 also has insulin-like effects on metabolism, influencing how cells use glucose and fats, linking growth signals with energy balance.

Why one steady number beats pulsatile growth hormone

Insulin-like growth factor 1 (IGF-1) is the liver's main messenger for growth hormone. It integrates growth hormone activity over time and signals how the body is building and repairing tissues. Because IGF-1 influences muscle, bone, metabolism, brain function, and even vascular health, it's a window into whole‑body anabolic balance and nutritional status.

An IGF-1 blood test measures the main growth signal made by the liver in response to growth hormone. Unlike growth hormone, which pulses, IGF-1 is relatively stable and reflects average GH activity. It tracks the body's anabolic tone—muscle and bone building, tissue repair, and cartilage health—and links to glucose handling, cardiovascular structure, cognition, reproduction, and immune function.

Reading IGF-1 against age-adjusted norms

Typical ranges are age- and sex-specific: highest in puberty, lower in later adulthood. For most adults, values in the middle of the age-adjusted range suggest balanced growth hormone signaling. During pregnancy, IGF-1 naturally rises as placental growth hormone takes the lead.

When IGF-1 runs low for age, it often reflects reduced growth hormone action, undernutrition, chronic illness, liver disease, or hypothyroidism. Adults may notice low energy, decreased muscle mass and strength, higher body fat, low bone density with fracture risk, and unfavorable lipids; mood and cognitive sharpness can dip. Children may grow slowly and fall off height curves. Women and older adults can see more bone effects; in teens, low values can blunt the pubertal growth spurt.

Low values usually reflect reduced growth hormone signaling or impaired liver production. This is seen with pituitary GH deficiency, undernutrition, chronic liver disease, too little thyroid hormone (hypothyroxinemia), poorly controlled type 1 diabetes (low portal insulin), chronic systemic illness, and with normal aging. System-level effects tend to be less anabolism: lower muscle and bone formation, higher fat mass, slower recovery, and in children, reduced linear growth.

Being in range suggests a balanced GH–IGF axis for your age and sex, adequate nutrition, and intact hepatic synthesis. This supports steady protein turnover, bone remodeling, and efficient glucose use. For adults, appropriate mid–reference values on an age- and sex-adjusted scale are typical; adolescents normally sit higher and older adults lower.

When IGF-1 is high for age, it points to excessive growth hormone activity or puberty/pregnancy physiology. Persistent elevation can cause acromegaly in adults (enlarged hands/feet, headaches, joint pain, sweating, sleep apnea, insulin resistance) and rapid linear growth in children. Chronically high levels have been linked to higher risks of cardiometabolic complications and some cancers.

High values usually reflect excess growth hormone exposure, most classically acromegaly from a pituitary adenoma. Levels also rise physiologically in puberty and pregnancy, and can be elevated with hyperthyroidism or renal impairment. Sustained high IGF-1 signals overactive growth pathways, often accompanied by soft-tissue and bone overgrowth, joint changes, insulin resistance, cardiometabolic strain, and sleep-disordered breathing.

What modifies IGF-1 interpretation

IGF-1 varies strongly with age, puberty, and pregnancy, and is influenced by illness, liver function, diabetes control, and thyroid status. Oral estrogens lower IGF-1; growth hormone therapy raises it. Assays differ; interpretation is most appropriate done with age/sex–adjusted reference ranges or a Z-score.

Aligning IGF-1 with age for whole-body anabolic balance

Big picture: IGF-1 sits at the crossroads of growth hormone, nutrition, insulin, thyroid function, liver health, and sex steroids. Keeping IGF-1 appropriately aligned for age supports musculoskeletal strength, metabolic stability, cognitive vitality, and long-term cardiovascular and bone outcomes.